jardiance
boehringer ingelheim international gmbh - empagliflozin - diabetes mellitus, type 2; heart failure; renal insufficiency, chronic - cukura diabēts - type 2 diabetes mellitusjardiance is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered in addition to other medicinal products for the treatment of diabetesfor study results with respect to combinations of therapies, effects on glycaemic control, and cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 un 5. of the annex. heart failurejardiance is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseasejardiance is indicated in adults for the treatment of chronic kidney disease.
thymanax
servier (ireland) industries ltd - agomelatīns - depresijas traucējumi, majors - psychoanaleptics, - lielu depresijas epizožu ārstēšana pieaugušajiem.
valdoxan
les laboratoires servier - agomelatīns - depresijas traucējumi, majors - psychoanaleptics, - lielu depresijas epizožu ārstēšana pieaugušajiem.
zilbea 25 mg apvalkotās tabletes
zentiva, k.s., czech republic - agomelatīns - apvalkotā tablete - 25 mg
agomelatine teva 25 mg apvalkotās tabletes
teva b.v., netherlands - agomelatīns - apvalkotā tablete - 25 mg
agodeprin 25 mg apvalkotās tabletes
sandoz d.d., slovenia - agomelatīns - apvalkotā tablete - 25 mg
agomelatine anpharm 25 mg apvalkotās tabletes
anpharm przedsiebiorstwo farmaceutyczne s.a., poland - agomelatīns - apvalkotā tablete - 25 mg
agomelatine mylan 25 mg apvalkotās tabletes
mylan pharmaceuticals limited, ireland - agomelatīns - apvalkotā tablete - 25 mg
lamegom 25 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - agomelatīns - apvalkotā tablete - 25 mg
irsamla 5 mg apvalkotās tabletes
egis pharmaceuticals plc, hungary - vortioksetīns - apvalkotā tablete - 5 mg